Log in or Sign up for Free to view tailored content for your specialty!
Genitourinary Cancer News
Enfortumab vedotin confers benefit ‘across the spectrum’ of advanced urothelial carcinoma
Results of two studies presented at Genitourinary Cancers Symposium showed treatment with enfortumab vedotin-ejfv benefited patients with locally advanced or metastatic urothelial carcinoma previously treated with a PD-1 or PD-L1 inhibitor.
ASCO names molecular profiling of gastrointestinal cancer ‘Advance of the Year’
ASCO has named molecular profiling driving progress in gastrointestinal cancer as its Advance of the Year, acknowledging improvements in treatment that have resulted from molecular testing of patients’ tumors.
Log in or Sign up for Free to view tailored content for your specialty!
Medical oncologist appointed chair of bladder cancer advisory board
Elizabeth Plimack, MD, MS, has been appointed chair of Bladder Cancer Advocacy Network’s scientific advisory board.
FDA approves first-line Opdivo-Cabometyx regimen for advanced renal cell carcinoma
The FDA approved nivolumab in combination with cabozantinib as first-line treatment of patients with advanced renal cell carcinoma, according to a manufacturer-issued press release.
FDA grants fast track designation to padeliporfin ImPACT for urothelial cancer subset
The FDA granted fast track designation to padeliporfin immune photo activated cancer treatment as treatment for adults with low-grade upper tract urothelial carcinoma.
US cancer mortality continues to decline at record pace
Overall cancer mortality in the U.S. decreased by 31% between 1991 and 2018 amid continued advances in lung cancer treatment, according to American Cancer Society’s 70th annual report on cancer statistics.
Obesity-associated cancers: An emergent problem among younger adults
The increasing prevalence and troubling consequences of obesity in the United States have been well-documented.
Noninvasive assay outperforms standard cytology in detection of urothelial carcinoma
A urine-based whole-genome sequencing assay demonstrated high specificity and comparable sensitivity to standard cytology for the detection of urothelial carcinoma, according to study results published in Clinical Cancer Research.
Diagnostic radiation below the waist may increase risk for testicular cancer
Exposure to diagnostic radiation below the waist may increase risk for testicular germ cell tumors, according to results of a case-control study published in PLOS One.
Training essential to understand cancer risks, address barriers facing LGBTQ individuals
Lesbian, gay, bisexual, transgender or queer individuals, or sexual and gender minorities, have been shown to have a disproportionate risk for cancer.